Impact of Halobetasol Propionate and Tazarotene Lotion 0.01%/0.045% in the Management of Plaque Psoriasis in Adults

Halobetasol propionate and tazarotene lotion 0.01%/0.045% (HP/TAZ) is a topical medication approved for the treatment of plaque psoriasis in adults. As a treatment modality, HP/TAZ has a combinatory therapeutic effect because it contains both a corticosteroid (HP) and a retinoid (TAZ) component. Her...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cosmet Investig Dermatol
Main Authors: Reddy, Vidhatha, Myers, Bridget, Yang, Eric J, Bhutani, Tina
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2020
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7295208/
https://ncbi.nlm.nih.gov/pubmed/32606876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CCID.S252426
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados